The superior disinfectant properties of ozone as compared to chlorine enthused scientists towards exploring its potential in the healthcare industry in the mid-nineteenth century. As studies claiming the effectiveness of ozone therapy in preventing bacterial growth began coming to light, the procedure caused a stir among therapists and physicians across the world. However, revolution, in the true sense, was led by German physician Dr. Hänsler, who manufactured the first modern ozone generator that became a benchmark for other physicians.
Since the very foundation of the ozone therapy market was laid in Germany, Europe gained the early slice of the revenue, and, even today, takes a leading stance. Despite the thriving of the healthcare industry in North America, the European ozone therapy market accounts for relatively three-fold revenue share. Legal frameworks applied to ozone in Europe are dependent upon its intended use, which widens its application in the healthcare industry. However, ozone therapy still awaits a legal designation in North America.
According to the U.S. FDA, ozone is deemed toxic with no useful medical application in adjunctive, preventive, or specific therapy, and exposure to ozone above a permissible degree can cause health hazards. However, in a handful of states with state-specific legislations, laws governing the use of non-allopathic medications approve ozone therapy for the treatment of certain illnesses. In addition, the American Academy of Ozonotherapy is offering ozone therapy training courses and spreading awareness regarding its antibacterial properties, which is entailing steady progress of the industry in the region.
Amidst the battle of legalization, the ozone therapy in dermatology market managed to record a value of ~ US$ 270 Mn in 2018.
Ozone is found to be an excellent ally for combating skin problems such as acne, herpes, and pimples, which has broadened the scope of its use in dermatology.
The ozone therapy in dermatology market in Europe grew ~ 45% in 2018 as compared to the previous year; its market value is more than the value of Asia Pacific and North American market combined. Under the current circumstances, wherein, scientific literature on the application of these devices in dermatology is increasing, players of the ozone therapy in dermatology market are looking at steady, albeit pedestrian growth in the next decade.
Use of Ozone Devices to Remain Prominent for Ozone Therapy
Ozone devices currently account for ~ 45% of share in the ozone therapy in dermatology market, surpassing topical medications. These exponential sales of ozone devices can be highly attributed to the demand for dermatological ozone therapy machines for treating eczema, acneiform eruption, and psoriasis, as ozone directly inactivates bacterial toxins. However, as the possibilities of developing resistance against antibiotics are high, the sales of topical medications are likely to grow steadily. Among the medications, ozonated oils and creams are perceived to have better healing times when applied on herpes labialis and bacterial tissues to regulate blood circulation, and are increasingly being prescribed by medical experts.
Patients Prefer Undergoing Ozone Therapy at Clinics
Clinics account for over half of the sales of ozone devices and topical medications. Since ozone therapy in dermatology falls under the category of an outpatient procedure, clinics are deemed suitable for patients who are affected by dermatological diseases. With lesser surgical instrument requisites, minimally invasive technique, and reduced healthcare costs, patients evince a marked preference for ozone therapies in clinics over hospitals. These trends are likely to shrink the contribution of hospitals from ~ 32% in 2018 to ~ 29% by 2027 in the ozone therapy in dermatology market.
Ozone Therapy in Dermatology Market - German Companies Take the Innovative Way to Grow Share
Ozone therapy has been practiced in Europe for over 50 years, and currently, ~11,000 therapists in Germany, ~3,500 in Russia, and ~3,000 therapists in Italy use ozone therapy in dermatology for achieving better patient outcomes. With a large base of therapists in Germany, research and development activities in the market have been accelerating in top gear.
In 2018, an innovative approach was taken by German companies to extend the traditional scope of ozone therapy by introducing ozone through direct administration for regulating blood circulation. A leading player - Dr. Hänsler Ozonosan - based in Germany, announced the launch of Ozonosan alpha plus, which is an integration of an ozone therapy unit with a photometric measuring unit, to facilitate continuous ozone level control. Besides the regular ozone applications, Ozonosan alpha plus offers major ozone infusion through a patient’s blood or rectal insufflation for circulation-enhancing effect.
Another German player - Humares GmbH - with utmost focus on stability, accuracy, quality, and simplicity, developed Humazona®, a device that offers versatile therapy for activating the immune system so as to create a revitalizing effect.
While a high concentration of market goliaths lies in Germany, owing to a growing number of patients opting for ozone therapy in dermatology market in Italy, the country is likely to spectate exponential growth in the region.
Ozone Therapy in Dermatology Market - Winning Imperatives for Players
As established players have access to better resources and loosened strings of R&D budgets, regional players face stiff competition in the landscape. Stringent regulatory norms in numerous regions further restrict their exposure, and the device approval process also comes at a high cost. This poses a question for regional and local players - How to achieve a better position in the market?
Ozone therapy in dermatology market is a landscape, wherein, the demand for devices and topical medications is drawing an upward trajectory, which can be capitalized on by market players vying for exposure. A cost-competitive strategy coupled with a strong support service can help position their products in prominent light.
Manufacturers operating in the ozone therapy in dermatology market can enter into long-term partnerships with clinics to continue gaining a reciprocal advantage. With government regulations turning lenient regarding the penetration of ozone devices in Asia Pacific, new market opportunities are likely to emerge for market players in this region.
Though the stakes in the ozone therapy in dermatology market are high, given the stringent scrutiny of products, and the availability of scientific literature, both, advocating and criticizing the use of ozone therapy in dermatology, market players need to be prepared to rapidly adapt to the shifting regulations and mirror the same in their growth strategies.
Advantages of Ozone Therapy: A Key Driver
Dermatological Ozone Therapy Machines to be Widely Used
Clinics to Gain Huge Popularity
Europe a prominent Ozone Therapy in Dermatology Market
Ozone Therapy in Dermatology Market: Competitive Landscape
Ozone Therapy in Dermatology Market: Business Strategies
Major manufacturers are adopting collaboration and partnership strategies to penetrate into the global ozone therapy in dermatology market and emerge as leaders dealing in ozone therapy products.
In the global ozone therapy in dermatology market report, we have provided the profiles of manufacturers of ozone therapy products. The ‘competitive landscape’ section is included in the report to provide readers with a dashboard view and a company footprint analysis of the key players operating in the global market.
Ozone Therapy in Dermatology Market Segmentation
This study on the use of ozone therapy in dermatology provides a detailed study of the market attractiveness, by analyzing the significant market segments. The global report, in turn, covers a country-wise analysis for comprehending the demand and supply ratio of the ozone therapy used for dermatology applications.
This exclusive report offers a thorough analysis based on the type of ozone therapies, end user, application, and region. Each of these segments is included and studied in this research report, in order to cull actionable insights regarding the growing use of ozone therapy in dermatology. This comprehensive guide on the ozone therapy in dermatology market provides historical, current, and futuristic trends influencing the growth of these segment, in particular, and the ozone therapy in dermatology market, in general. In addition to this, it provides value chain analysis, Y-o-Y growth analysis, and supply chain analysis of the use of ozone therapy in dermatology.
|
Type |
Devices
Medications
|
|
End User |
Hospitals Clinics Others |
|
Application |
Eczema Herpes Acneiform Eruption Psoriasis Mycosis Others |
|
Region |
North America Europe Latin America Asia Pacific Middle East & Africa |
Ozone therapy in dermatology market to reach a value of ~US$ 400 Mn by 2027
Ozone therapy in dermatology market is anticipated to expand at a CAGR of 5% from 2019 to 2027
Ozone therapy in dermatology market is driven by rise in product launches, increase in partnerships & collaborations to enhance product availability
Europe accounted for a major share of the global ozone therapy in dermatology market
Key players in the global ozone therapy in dermatology market include MEDOZONS Ltd., Zotzmann + Stahl GmbH + Co. KG, The Ozone Company, Promolife
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Acronyms
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Overview
5.2. Market Dynamics
5.2.1. Drivers
5.2.1.1. Advantages of Ozone Therapy
5.2.1.2. Rise in prevalence of skin diseases
5.2.1.3. Increase in number of ozone therapy practitioners
5.2.1.4. Establishment of associations with focus on ozone therapy
5.2.2. Restraints
5.2.2.1. Limitations of ozone therapy
5.2.2.2. Ban on usage of ozone therapy for medical purposes
5.2.3. Opportunities
5.2.3.1. Versatility of ozone therapy
5.2.3.2. Usage of ozone therapy as combination therapy
5.2.4. Global Ozone Therapy in Dermatology Market Revenues (US$ Mn) Forecast, 2017–2027
5.2.5. Global Ozone Therapy in Dermatology Market Outlook
5.2.6. Technological Assessment
5.2.7. Disease Prevalence Assessment, by Application
6. Global Ozone Therapy in Dermatology Market Analysis, by Type
6.1. Introduction
6.2. Market Value Share Analysis, by Type
6.3. Market Value Forecast, by Type, 2017–2027
6.3.1. Devices
6.3.1.1. Dermatological Ozone Therapy Devices
6.3.1.2. Ozone Generators
6.3.1.3. Ozonated Saline
6.3.1.4. Ozone Syringes
6.3.1.5. Others
6.3.2. Topical Medications
6.3.2.1. Ozonated Oil & Creams
6.3.2.2. Others
6.4. Market Attractiveness, by Type
6.5. Key Trends
7. Global Ozone Therapy in Dermatology Market Analysis, by Application
7.1. Introduction
7.2. Market Value Share Analysis, by Application
7.3. Market Value Forecast, by Application, 2017–2027
7.3.1. Eczema
7.3.2. Herpes
7.3.3. Acneiform Eruption
7.3.4. Psoriasis
7.3.5. Mycosis
7.3.6. Others
7.4. Market Attractiveness, by Application
7.5. Key Trends
8. Global Ozone Therapy in Dermatology Market Analysis, by End-user
8.1. Introduction
8.2. Market Value Share Analysis, by End-user
8.3. Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
8.5. Key Trends
9. Global Ozone Therapy in Dermatology Market Analysis, by Region
9.1. Global Market Scenario
9.2. Introduction
9.3. Market Value Share Analysis, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Latin America
9.3.4. Asia Pacific
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
9.5. Key Trends
10. North America Ozone Therapy in Dermatology Market Analysis
10.1. Market Outlook
10.2. Market Value Forecast, by Country, 2017–2027
10.2.1. U.S.
10.2.2. Canada
10.3. Market Value Forecast, by Type, 2017–2027
10.3.1. Devices
10.3.1.1. Dermatological Ozone Therapy Devices
10.3.1.2. Ozone Generators
10.3.1.3. Ozonated Saline
10.3.1.4. Ozone Syringes
10.3.1.5. Others
10.3.2. Topical Medications
10.3.2.1. Ozonated Oil & Creams
10.3.2.2. Others
10.4. Market Value Forecast, by Application, 2017–2027
10.4.1. Eczema
10.4.2. Herpes
10.4.3. Acneiform Eruption
10.4.4. Psoriasis
10.4.5. Mycosis
10.4.6. Others
10.5. Market Value Forecast, by End-user, 2017–2027
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Others
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Type
10.6.3. By Application
10.6.4. By End-user
11. Europe Ozone Therapy in Dermatology Market Analysis
11.1. Market Outlook
11.2. Market Value Forecast, by Country/Sub-region, 2017–2027
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Market Value Forecast, by Type, 2017–2027
11.3.1. Devices
11.3.1.1. Dermatological Ozone Therapy Devices
11.3.1.2. Ozone Generators
11.3.1.3. Ozonated Saline
11.3.1.4. Ozone Syringes
11.3.1.5. Others
11.3.2. Topical Medications
11.3.2.1. Ozonated Oil & Creams
11.3.2.2. Others
11.4. Market Value Forecast, by Application, 2017–2027
11.4.1. Eczema
11.4.2. Herpes
11.4.3. Acneiform Eruption
11.4.4. Psoriasis
11.4.5. Mycosis
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2017–2027
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Others
11.6. Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Type
11.6.3. By Application
11.6.4. By End-user
12. Asia Pacific Ozone Therapy in Dermatology Market Analysis
12.1. Market Outlook
12.2. Market Value Forecast, by Country/Sub-region, 2017–2027
12.2.1. China
12.2.2. Japan
12.2.3. India
12.2.4. Australia
12.2.5. Rest of Asia Pacific
12.3. Market Value Forecast, by Type, 2017–2027
12.3.1. Devices
12.3.1.1. Dermatological Ozone Therapy Devices
12.3.1.2. Ozone Generators
12.3.1.3. Ozonated Saline
12.3.1.4. Ozone Syringes
12.3.1.5. Others
12.3.2. Topical Medications
12.3.2.1. Ozonated Oil & Creams
12.3.2.2. Others
12.4. Market Value Forecast, by Application, 2017–2027
12.4.1. Eczema
12.4.2. Herpes
12.4.3. Acneiform Eruption
12.4.4. Psoriasis
12.4.5. Mycosis
12.4.6. Others
12.5. Market Value Forecast, by End-user, 2017–2027
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Others
12.6. Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Type
12.6.3. By Application
12.6.4. By End-user
13. Latin America Ozone Therapy in Dermatology Market Analysis
13.1. Market Outlook
13.2. Market Value Forecast, by Country/Sub-region, 2017–2027
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Market Value Forecast, by Type, 2017–2027
13.3.1. Devices
13.3.1.1. Dermatological Ozone Therapy Devices
13.3.1.2. Ozone Generators
13.3.1.3. Ozonated Saline
13.3.1.4. Ozone Syringes
13.3.1.5. Others
13.3.2. Topical Medications
13.3.2.1. Ozonated Oil & Creams
13.3.2.2. Others
13.4. Market Value Forecast, by Application, 2017–2027
13.4.1. Eczema
13.4.2. Herpes
13.4.3. Acneiform Eruption
13.4.4. Psoriasis
13.4.5. Mycosis
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2017–2027
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Others
13.6. Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Type
13.6.3. By Application
13.6.4. By End-user
14. Section 14 Middle East & Africa Ozone Therapy in Dermatology Market Analysis
14.1. Key Findings
14.2. Market Value Forecast, by Country/Sub-region, 2017–2027
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of Middle East & Africa
14.3. Market Value Forecast, by Type, 2017–2027
14.3.1. Devices
14.3.1.1. Dermatological Ozone Therapy Devices
14.3.1.2. Ozone Generators
14.3.1.3. Ozonated Saline
14.3.1.4. Ozone Syringes
14.3.1.5. Others
14.3.2. Topical Medications
14.3.2.1. Ozonated Oil & Creams
14.3.2.2. Others
14.4. Market Value Forecast, by Application, 2017–2027
14.4.1. Eczema
14.4.2. Herpes
14.4.3. Acneiform Eruption
14.4.4. Psoriasis
14.4.5. Mycosis
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2017–2027
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Others
14.6. Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Type
14.6.3. By Application
14.6.4. By End-user
15. Competition Landscape
15.1. Market Footprint Analysis, 2018
15.2. Company Profiles
15.2.1. Apoza Enterprise Co., Ltd.
15.2.2. Dr. J. Hänsler GmbH
15.2.3. Humares GmbH
15.2.4. O3organics
15.2.5. Ozolabs, LLC
15.2.6. Promolife
15.2.7. The Ozone Company
15.2.8. Zotzmann + Stahl GmbH + Co. KG
15.2.9. MEDOZONS Ltd.
List of Tables
Table 01: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 02: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 03: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 04: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 09: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 10: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 11: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: North America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 15: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 16: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 17: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 21: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 22: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 23: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 27: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 28: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 29: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 30: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 31: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 32: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 33: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 34: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Topical Medications, 2017–2027
Table 35: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 36: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Ozone Therapy in Dermatology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 02: Global Market Value Share, by Type, 2018
Figure 03: Global Market Value Share, by Application, 2018
Figure 04: Global Market Value Share, by End-user, 2018
Figure 05: Global Market Value Share, by Region, 2018
Figure 06: Global Ozone Therapy in Dermatology Market Value Share, by Devices, 2018 and 2027
Figure 07: Global Ozone Therapy in Dermatology Market Value Share, by Topical Medications, 2018 and 2027
Figure 08: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Devices, 2017–2027
Figure 09: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical Medications, 2017–2027
Figure 10: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dermatological Ozone Therapy Machines, 2017–2027
Figure 11: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ozone Generators, 2017–2027
Figure 12: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ozonated Saline, 2017–2027
Figure 13: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ozone Syringes, 2017–2027
Figure 14: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 15: Global Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019–2027
Figure 16: Global Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019–2027
Figure 17: Global Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019–2027
Figure 18: Global Ozone Therapy in Dermatology Market Value Share, by Application, 2018 and 2027
Figure 19: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Eczema, 2017–2027
Figure 20: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Herpes, 2017–2027
Figure 21: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Acneiform Eruption, 2017–2027
Figure 22: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Psoriasis, 2017–2027
Figure 23: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mycosis, 2017–2027
Figure 24: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 25: Global Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019–2027
Figure 26: Global Ozone Therapy in Dermatology Market Value Share, by End-user, 2018 and 2027
Figure 27: Global Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019–2027
Figure 28: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 29: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2017–2027
Figure 30: Global Ozone Therapy in Dermatology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 31: Global Ozone Therapy in Dermatology Market Value Share, by Region, 2018 and 2027
Figure 32: Global Ozone Therapy in Dermatology Market Attractiveness, by Region, 2019 - 2027
Figure 33: North America Ozone Therapy in Dermatology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: North America Ozone Therapy in Dermatology Market Attractiveness Analysis, by Country, 2019–2027
Figure 35: North America Ozone Therapy in Dermatology Market Value Share Analysis, by Country, 2018 and 2027
Figure 36: North America Ozone Therapy in Dermatology Market Value Share Analysis, by Type, 2018 and 2027
Figure 37: North America Ozone Therapy in Dermatology Market Value Share Analysis, by Devices, 2018 and 2027
Figure 38: North America Ozone Therapy in Dermatology Market Value Share Analysis, by Topical Medications, 2018 and 2027
Figure 39: North America Ozone Therapy in Dermatology Market Value Share Analysis, by Application, 2018 and 2027
Figure 40: North America Ozone Therapy in Dermatology Market Value Share Analysis, by End-user, 2018 and 2027
Figure 41: North America Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019?2027
Figure 42: North America Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019?2027
Figure 43: North America Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019?2027
Figure 44: North America Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019?2027
Figure 45: North America Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019?2027
Figure 46: Europe Ozone Therapy in Dermatology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 47: Europe Ozone Therapy in Dermatology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 48: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 49: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by Type, 2018 and 2027
Figure 50: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by Devices, 2018 and 2027
Figure 51: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by Topical Medications, 2018 and 2027
Figure 52: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by Application, 2018 and 2027
Figure 53: Europe Ozone Therapy in Dermatology Market Value Share Analysis, by End-user, 2018 and 2027
Figure 54: Europe Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019?2027
Figure 55: Europe Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019?2027
Figure 56: Europe Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019?2027
Figure 57: Europe Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019?2027
Figure 58: Europe Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019?2027
Figure 59: Asia Pacific Ozone Therapy in Dermatology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 60: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 61: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 62: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by Type, 2018 and 2027
Figure 63: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by Devices, 2018 and 2027
Figure 64: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by Topical Medications, 2018 and 2027
Figure 65: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by Application, 2018 and 2027
Figure 66: Asia Pacific Ozone Therapy in Dermatology Market Value Share Analysis, by End-user, 2018 and 2027
Figure 67: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019?2027
Figure 68: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019?2027
Figure 69: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019?2027
Figure 70: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019?2027
Figure 71: Asia Pacific Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019?2027
Figure 72: Latin America Ozone Therapy in Dermatology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 73: Latin America Ozone Therapy in Dermatology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 74: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 75: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by Type, 2018 and 2027
Figure 76: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by Devices, 2018 and 2027
Figure 77: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by Topical Medications, 2018 and 2027
Figure 78: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by Application, 2018 and 2027
Figure 79: Latin America Ozone Therapy in Dermatology Market Value Share Analysis, by End-user, 2018 and 2027
Figure 80: Latin America Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019?2027
Figure 81: Latin America Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019?2027
Figure 82: Latin America Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019?2027
Figure 83: Latin America Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019?2027
Figure 84: Latin America Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019?2027
Figure 85: Middle East & Africa Ozone Therapy in Dermatology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 86: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 87: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 88: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by Type, 2018 and 2027
Figure 89: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by Devices, 2018 and 2027
Figure 90: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by Topical Medications, 2018 and 2027
Figure 91: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by Application, 2018 and 2027
Figure 92: Middle East & Africa Ozone Therapy in Dermatology Market Value Share Analysis, by End-user, 2018 and 2027
Figure 93: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness, by Type, 2019?2027
Figure 94: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness, by Devices, 2019?2027
Figure 95: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness, by Topical Medications, 2019?2027
Figure 96: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness, by Application, 2019?2027
Figure 97: Middle East & Africa Ozone Therapy in Dermatology Market Attractiveness, by End-user, 2019?2027
Figure 98: Market Footprint Analysis
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Ozone Therapy in Dermatology Market
